Sanofi to Buy Synthorx for $2.5 Billion


Dec.09 -- M&A Monday has begun with another big deal in the biotech space. Sanofi has agreed to buy U.S.-based Synthorx in a buyout worth approximately $2.5 billion. Bloomberg's Sarah Syed reports on "Bloomberg Markets: European Open."


More Related News

Uber's delivery business is now larger than ride-hailing

Uber's delivery business - better known as Uber Eats - is now bigger than its original and core ride-hailing division, based on adjusted net revenue. Now, adjusted net revenue tells only a piece of this evolving Uber story. Income, or losses in the case of Uber's delivery business, are also important.

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply


Top News: Economy